Clinical Trials Logo

Filter by:
NCT ID: NCT03923361 Withdrawn - Clinical trials for Treatment Resistant Depression

Neural and Antidepressant Effects of Propofol (Phase 2)

Start date: April 16, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Moderate-intensity propofol treatments will be administered to participants who are non-responders at the end of Phase 1.

NCT ID: NCT03923257 Withdrawn - Clinical trials for Neuroendocrine Tumors

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Start date: August 4, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Phase I/II peptide receptor radiotherapy (PRRT) trial of 177Lu-DOTA-OCTREOTATE in children and adolescents with neuroendocrine tumors and pheochromocytoma or paraganglioma.

NCT ID: NCT03921476 Withdrawn - Acne Vulgaris Clinical Trials

Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function

Start date: July 1, 2020
Phase:
Study type: Observational

This study seeks to examine if there is any relationship between spironolactone use prescribed for acne vulgaris and depression, anxiety, and/or sexual function.

NCT ID: NCT03920878 Withdrawn - Cataract Clinical Trials

Cataract DME - Peri vs. Intraop

Start date: May 2020
Phase: Phase 2
Study type: Interventional

Goals of the study are to evaluate how peri-operative versus intra-operative anti-VEGF intravitreous injections affect visual acuity (BCVA) in patients with persistent diabetic macular edema who are undergoing cataract surgery; and to evaluate how peri-operative versus intra-operative anti-VEGF intravitreous injections affect OCT CSF thickness and total number of postoperative injections in patients with diabetic macular edema who are undergoing cataract surgery.

NCT ID: NCT03920631 Withdrawn - B Cell Lymphomas Clinical Trials

Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas

MicroBLITZ
Start date: July 10, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find out if microtransplantation (MST) in combination with nivolumab is safe and effective in patients with relapsed or refractory B cell lymphomas.

NCT ID: NCT03919708 Withdrawn - Amblyopia Clinical Trials

Amblyopia and Strabismus Detection Using Retinal Birefringence Imaging

RBI
Start date: February 4, 2020
Phase:
Study type: Observational

The purpose of this project is to compare the accuracy of two products at detecting amblyopia and strabismus in children. The devices will be Rebiscan's "blinq" (Pediatric Vision Scanner; PVS) and Rebiscan's RBI (Retinal Birefringence Imager).

NCT ID: NCT03912792 Withdrawn - XLHED Clinical Trials

A Cross-Sectional Natural History Study to Evaluate Sweat Volume and Other Phenotypic and Genetic Characteristics in Patients Affected by XLHED

Start date: June 28, 2019
Phase:
Study type: Observational

The proposed natural history study will enroll male patients with a diagnosis of XLHED, female carriers of XLHED and healthy volunteers. The study protocol will include collection of XLHED questionnaires and clinical outcomes using minimally invasive technologies. Data will be collected both retrospectively and prospectively. Clinical outcome assessments will be performed at the NFED Family Conference on July 11-12, 2019. Study participants will be able to complete XLHED questionnaires electronically ahead of the conference.

NCT ID: NCT03912116 Withdrawn - Clinical trials for Osteoarthritis: Joint Replacement Surgery

Amniotic Umbilical Cord Particulate During Total Knee Arthroplasty

Start date: April 9, 2019
Phase: N/A
Study type: Interventional

Total knee arthroplasty (TKA) is the most common joint replacement surgery and its incidence is expected to increase 673% to 3.48 million procedures annually by 2030. After more than 20 years of follow-up data, TKA is confirmed to be an effective treatment for knee osteoarthritis, however, postoperative pain management continues to be a challenge despite advances in surgical techniques and anesthetic practice to minimize discomfort and enhance recovery. This acute post-surgical pain caused by extensive tissue damage and inflammation in TKA leads to restricted post-operative knee range of motion (ROM) and ability to mobilize.

NCT ID: NCT03911063 Withdrawn - Clinical trials for Familial Dysautonomia

Telemedicine Clinical Trial for Cognitive Behavioral Therapy in Familial Dysautonomia

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

This is a single-blind, placebo-controlled, telemedicine clinical trial to assess the efficacy of cognitive behavioral therapy (CBT) in adult patients 18 years and older with familial dysautonomia (FD) and anxiety and/or depression and/or obsessive compulsive or related disorders. The trial will enroll 20 adult patients each with FD who have anxiety and/or depression and/or obsessive compulsive or related disorders by the DSM V criteria. Enrolled participants will be allocated to receive, in a non-randomized fashion, weekly 5-10 min talking sessions (i.e., placebo) for 8 weeks, followed by weekly 30-60 min CBT sessions during 8 weeks. Although investigators will be un-blinded to the intervention, participants will be blinded to the expected effects of each intervention. Both the talking sessions (i.e., placebo) and CBT sessions will be performed via telemedicine either via a HIPAA secure telemedicine platform or the telephone based on the preference of the individual patient. If a patient specifically requests talking or CBT sessions to be performed in person, this will be accommodated. The use of telemedicine is to accommodate disability and potential physical limitations of this unique patient population. The CBT sessions will be supervised by Lily Armstrong, certified mental health therapist and Dr. Thomas Boes, NYU Clinical Assistant Professor in the Departments of Psychiatric and Neurology.

NCT ID: NCT03910790 Withdrawn - Liver Biopsy Clinical Trials

Liver Biopsy Using a 19 Gauge Fine Needle Biopsy Needle

Start date: March 20, 2019
Phase: N/A
Study type: Interventional

A 19 gauge FNB needle, using same technique as with 22 gauge needle, to obtain liver histological specimen in regards to core length and the number of Complete Portal Triads.